Immunovaccine Announces Positive Clinical Data from Collaborative Combination Immunotherapy Trial in Advanced … – Drug Discovery & Development
Drug Discovery & Development |
Immunovaccine Announces Positive Clinical Data from Collaborative Combination Immunotherapy Trial in Advanced …
Drug Discovery & Development Immunovaccine Inc, a clinical stage immuno-oncology company, announced positive top-line clinical data from its ongoing Phase 1b trial evaluating the safety and efficacy of Immunovaccine's lead immuno-oncology candidate, DPX-Survivac, in combination … |
